Study of SZN-8141 for diabetic macular edema
Part of Eyes & vision clinical trials.
This study tests a new medicine called SZN-8141 for people with diabetic macular edema (DME), a condition that causes swelling in the back of the eye due to diabetes. The medicine is given as an injection into the eye, and the goal is to reduce swelling and improve vision.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 90 years old.
- You have type 1 or type 2 diabetes.
- Your diabetes is fairly well controlled (HbA1c of 12% or less).
- You have swelling in the center of your retina (the back of the eye) that is caused by diabetes.
- Your vision in the study eye is between 20/40 and 20/200 (like a standard eye chart).
- You have not had certain eye surgeries or laser treatments in the study eye, and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication, CU06-1004, for people with diabetic macular edema, a condition that causes blurry vision due to fluid buildup in the central part of the retina. The goal is to see if this drug can reduce the swelling and improve vision.
This study tests a new gene therapy called LX111 for diabetic macular edema (DME) that has not improved enough with previous injections. It aims to see if a single treatment can reduce swelling and improve vision.
This study tests an experimental eye injection (OLN324) for people with diabetic macular edema, a condition where swelling in the back of the eye causes vision loss. The goal is to see if the injection can improve vision.
This study tests a treatment for diabetic macular edema (swelling in the back of the eye caused by diabetes) in people who have not had eye injections before. It aims to see if the treatment can improve vision.
This trial tests an eye injection called OLN324 for diabetic macular edema, a condition where fluid builds up in the retina and blurs vision. The treatment aims to improve vision and reduce swelling in the eye.
This study tests an oral medication that may reduce swelling in the retina caused by diabetes. If you have diabetic macular edema affecting your central vision, this trial could help you preserve or improve your sight.
Hear when a new Diabetic Macular Edema (DME) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.